Biospring Partners is a growth equity firm that leverages sector experience to partner with companies addressing global challenges.

Jennifer Lum

Michelle Dipp

Biospring Partners

Biospring Partners is a growth equity firm that invests in Life Sciences Technology. Biospring leverages its deep experience in life sciences and technology to support B2B services, tools, and enterprise software companies that are driving innovation across the life sciences industry.

Twitter: @biosprings

KINICITI

Abzena

#AI is revolutionizing our understanding of protein-DNA interactions, paving the way for data-driven proteomics, drug discovery, and advancements in synthetic biology.

#synbio SynBioBeta

https://lnkd.in/enfZNpSx

Congratulations to the team at Abzena for winning "Best Performing R&D Service Provider of the Year" at the One Nucleus Awards.

Harvard University and Google Research have come together to create the largest 3D brain reconstruction to date.

https://lnkd.in/e7k_MZjH

We were delighted to host founders, industry leaders, and investors to discuss the future of the life science industry in Boston.

The intersection of science and technology can be fascinating yet challenging. Join our established professionals as we delve deep into the latest trends emerging in Life Sciences VC and discover how they have successfully positioned themselves in the industry today. Click here for more info and registration: https://lnkd.in/e6ASiCZ8
#bioscience #healthtech

Jennifer Lum Arjun Goyal, M.D. Richard Lim Nuné Martiros, PhD I-hung Shih

Google DeepMind, in collaboration with Isomorphic Labs, has introduced AlphaFold 3, an #AI model capable of predicting the structure and interactions of all life's molecules. 

https://lnkd.in/dKDiwBKq

Metric
Company Name	Biospring Partners
Symbol
MSH ID	COM:BIOSPRING
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Management
Country	US
Stage
Employee Count	10
Website	biospring.com
LinkedIn	biospringpartners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	282
Web Traffic Growth	-0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BIOSPRING

Biospring Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue